The promise of minocycline in neurology
V. Wee Yong(University of Calgary), Luanne M. Metz(Foothills Medical Centre), Jennifer Wells(University of Calgary), Christopher Power(University of Alberta), Fabrizio Giuliani(University of Alberta), Steven Casha(University of Calgary)
Cited by 521
Related Papers
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
|Nature Medicine|2007|1.8k
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
The Role of Inflammation in Depression and Fatigue
|Frontiers in Immunology|2019|651
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624